findmyKOL
Clinical trialNCT04916613RecruitingPhase 3Interventional

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

SponsorUNICANCEREnrollment300Prostate Cancer Metastatic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

95 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Grand Hopital de Charleroi - Site Notre Dame

    Charleroi, Belgium

    Recruiting
  • Groupe Jolimont - Hôpital de Jolimont

    Haine-Saint-Paul, Belgium

    Recruiting
  • Chu Ucl Namur - Site Ste. Elisabeth

    Namur, Belgium

    Recruiting
  • Clinique Saint Pierre

    Ottignies, Belgium

    Recruiting
France
  • Institut Sainte Catherine

    Avignon, France

    Recruiting
  • Centre Hospitalier Cote Basque

    Bayonne, France

    Recruiting
  • Chu Besançon - Hopital Jean Mijoz

    Besançon, France

    Recruiting
  • Centre Pierre Curie

    Beuvry, France

    Recruiting
  • Centre Institut Bergonié

    Bordeaux, France

    Recruiting
  • Clinique Pasteur

    Brest, France

    Recruiting
  • Centre François Baclesse

    Caen, France

    Recruiting
  • Centre Hospitalier Métropole Savoie

    Chambéry, France

    Recruiting
  • Centre Jean Perrin

    Clermont-Ferrand, France

    Recruiting
  • Ch Colmar

    Colmar, France

    Recruiting
  • Aphp - Hôpital Henri Mondor

    Créteil, France

    Recruiting
  • Centre Georges François Leclerc

    Dijon, France

    Recruiting
  • Chu Grenoble

    Grenoble, France

    Recruiting
  • Centre Chv Vendée

    La Roche-sur-Yon, France

    Recruiting
  • Chu Sud Réunion

    La Réunion, France

    Not, yet, recruiting
  • Chu Le Mans

    Le Mans, France

    Recruiting
  • Centre Oscar Lambret

    Lille, France

    Recruiting
  • Polyclinique de Limoges

    Limoges, France

    Recruiting
  • Groupe Hospitalier Bretagne Sud

    Lorient, France

    Recruiting
  • Centre Léon Bérard

    Lyon, France

    Recruiting
  • Institut Paoli-Calmettes

    Marseille, France

    Recruiting
  • Ch Mont de Marsan

    Mont-de-Marsan, France

    Recruiting
  • Centre Azuréen de Cancérologie

    Mougins, France

    Recruiting
  • Centre Antoine Lacassagne

    Nice, France

    Recruiting
  • Chu Nîmes

    Nîmes, France

    Recruiting
  • Centre Groupe Hospitalier Diaconesses Croix Saint-Simon

    Paris, France

    Recruiting
  • Hôpital Européen Georges Pompidou

    Paris, France

    Recruiting
  • Hôpital Saint Louis

    Paris, France

    Recruiting
  • Hôpital Tenon

    Paris, France

    Recruiting
  • Hospices Civils de Lyon -Lyon Sud

    Pierre-Bénite, France

    Recruiting
  • Chu de Poitiers - Pôle Régional de Cancérologie

    Poitiers, France

    Recruiting
  • Ch Annecy Genevois

    Pringy, France

    Recruiting
  • Chic Quimper

    Quimper, France

    Recruiting
  • Institut Jean Godinot

    Reims, France

    Recruiting
  • Centre Eugène Marquis

    Rennes, France

    Recruiting
  • Centre Eugène Marquis - Rennes

    Rennes, France

    Recruiting
55 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Apr 2022
Primary completion
31 Mar 2028
Completion
30 Sept 2037
Last update posted
28 Apr 2026
Registered enrollment
300
Registry id
NCT04916613

Cross-registrations

EU-CTR / CTIS (EudraCT)2022-502425-18-00EU-CTR / CTIS (EudraCT)2020-003663-26

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.